Israel Englander’s Evolent Health EVH Stock Holding History

Israel Englander’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-150,000	Closed	-$1.42M	–	5982
2025 Q1	$1.42M	Buy	+150,000	New	+$1.52M	﹤0.01%	4092
2024 Q4	–	Sell	-176,500	Closed	-$4.99M	–	6078
2024 Q3	$4.99M	Buy	+176,500	New	+$4.55M	﹤0.01%	2842
2024 Q2	–	Sell	-30,300	Closed	-$994K	–	6054
2024 Q1	$994K	Buy	+30,300	New	+$967K	﹤0.01%	4295
2023 Q1	–	Sell	-275,000	Closed	-$7.72M	–	6490
2022 Q4	$7.72M	Buy	+275,000	New	+$7.88M	﹤0.01%	2398
2022 Q2	–	Sell	-150,000	Closed	-$4.84M	–	7103
2022 Q1	$4.84M	Buy	+150,000	New	+$3.93M	﹤0.01%	2973
2021 Q4	–	Sell	-149,700	Closed	-$4.64M	–	6953
2021 Q3	$4.64M	Buy	+149,700	New	+$3.59M	﹤0.01%	2949
2019 Q4	–	Sell	-359,200	Closed	-$2.58M	–	4321
2019 Q3	$2.58M	Buy	+359,200	New	+$2.58M	﹤0.01%	2282
2019 Q1	–	Sell	-30,000	Closed	-$599K	–	4053
2018 Q4	$599K	Buy	+30,000	New	+$694K	﹤0.01%	2850
2018 Q3	–	Sell	-160,000	Closed	-$3.37M	–	4003
2018 Q2	$3.37M	Buy	+160,000	New	+$3.03M	﹤0.01%	2060

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Israel Englander's EVH Position: Q2 2026 in Review

Israel Englander reduced its Evolent Health (EVH) stake by 19% in Q2 2026, selling an estimated $278K and leaving 303,343 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #3972.

Israel Englander first reported a position in EVH in Q2 2015 and has held it in 44 quarters since. The position peaked at $65.5M in Q1 2023. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Israel Englander held 303,343 shares of Evolent Health worth $1.64M as of Q2 2026.
Israel Englander sold 72,456 Evolent Health shares in Q2 2026, an estimated $278K.
Evolent Health made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3972 holding.
Israel Englander first reported a position in Evolent Health in Q2 2015 and has held it in 44 quarters since.
Israel Englander's Evolent Health position peaked at $65.5M in Q1 2023.
198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.